Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-05-22		NCT06326021

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing GoBroad Hospital	42
Ruijin Hospital	454
Shanghai Liquan Hospital	11
The General Hospital of Western Theater Command	26
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai	6

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BeijingGoBroadH	Beijing	China	1
Shanghai Liquan Hospital	Shanghai	China	4
The General Hospital of Western Theater Command PLA	Chengdu	China	4
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai	Shanghai	China	3